Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Pharmacy and Pharmaceutical Sciences (20)
- Chemicals and Drugs (15)
- Virus Diseases (13)
- Other Pharmacy and Pharmaceutical Sciences (12)
- Amino Acids, Peptides, and Proteins (10)
-
- Medical Sciences (8)
- Medicinal and Pharmaceutical Chemistry (8)
- Medical Biochemistry (6)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (4)
- Life Sciences (4)
- Pharmaceutics and Drug Design (4)
- Pharmacy Administration, Policy and Regulation (3)
- Therapeutics (3)
- Animal Experimentation and Research (2)
- Animals (2)
- Biology (2)
- Enzymes and Coenzymes (2)
- Health and Medical Administration (2)
- Hemic and Lymphatic Diseases (2)
- Immunology and Infectious Disease (2)
- Medical Specialties (2)
- Nanomedicine (2)
- Nanotechnology (2)
- Nucleic Acids, Nucleotides, and Nucleosides (2)
- Organisms (2)
- Research Methods in Life Sciences (2)
- Social and Behavioral Sciences (2)
- Keyword
-
- HIV (5)
- Nucleoside (4)
- AIDS (3)
- Drug delivery (3)
- FLT (3)
-
- Reverse transcriptase (3)
- 1 (2)
- AZT (2)
- Anti-HIV (2)
- Dextran Prodrugs (2)
- HIV-1 (2)
- Immunosuppression (2)
- KSHV (2)
- Macromolecular Prodrugs (2)
- Methylprednisolone (2)
- Peptide Linkers (2)
- Pharmacokinetics (2)
- Pre-exposure prophylaxis (2)
- (Acyloxy) Alkyl (1)
- (HIV) infection (1)
- 2 (1)
- 2'3'-Dideoxynucleosides (1)
- 3'-Azido-2'3'-dideoxythymidine (AZT) (1)
- 3-Triazole (1)
- 3TC (1)
- 4-Dihydro-1-methyl-3-[(pyridylcarbonyl)oxy]ester (1)
- 4-dihydro-1-methyl-3-pyridinylcarboxylic acid (1)
- 5'-O-Aliphatic derivatives of AZT (1)
- 5'-O-Ester prodrugs (1)
- 5'-O-Myristoyl derivatives of AZT (1)
- Publication Year
Articles 31 - 33 of 33
Full-Text Articles in Immune System Diseases
Synthesis, Antiviral And Contraceptive Activities Of Nucleoside-Sodium Cellulose Sulfate Acetate And Succinate Conjugates, Hitesh K. Agarwal, Anil Kumar, Gustavo F. Doncel, Keykavous Parang
Synthesis, Antiviral And Contraceptive Activities Of Nucleoside-Sodium Cellulose Sulfate Acetate And Succinate Conjugates, Hitesh K. Agarwal, Anil Kumar, Gustavo F. Doncel, Keykavous Parang
Pharmacy Faculty Articles and Research
Chemical conjugates between sodium cellulose sulfate (CS), displaying contraceptive and HIV-entry inhibiting properties, and nucleoside reverse transcriptase inhibitors (NRTIs) (3′-azido-2′,3′-dideoxythymidine (AZT), 3′-fluoro-2′,3′-dideoxythymidine (FLT), or 2',3'-dideoxy-3'-thiacytidine (3TC)) were designed to simultaneously provide contraceptive and anti-HIV activity. Two linkers, acetate and succinate, were used to conjugate the nucleoside analogs with CS. The conjugates containing cellulose sulfate-acetate (CSA) (e.g., AZT-CSA and FLT-CSA) were found to be more potent than CS and other conjugates (e.g., AZT-succinate-CS, and FLT-succinate-CS). The presence of both sulfate and the acetate groups on cellulose were critical for generating maximum anti-HIV activity. In addition to showing equal potency against wild-type …
Novel Approaches For Designing 5'-O-Ester Prodrugs Of 3'-Azido-2'3'-Dideoxythymidine (Azt), Keykavous Parang, Leonard I. Wiebe, Edward E. Knaus
Novel Approaches For Designing 5'-O-Ester Prodrugs Of 3'-Azido-2'3'-Dideoxythymidine (Azt), Keykavous Parang, Leonard I. Wiebe, Edward E. Knaus
Pharmacy Faculty Articles and Research
3'-Azido-2'3'-dideoxythymidine (AZT, 1, zidovudine, RetrovirTM) is used to treat patients with human immunodeficiency virus (HIV) infection. AZT, after conversion to AZT-5'-triphosphate (AZT-TP) by cellular enzymes, inhibits HIV-reverse transcriptase (HIV-RT). The major clinical limitations of AZT are due to clinical toxicities that include bone marrow suppression, hepatic abnormalities and myopathy, absolute dependence on host cell kinase-mediated activation which leads to low activity, limited brain uptake, a sort half-life of about one hour in plasma that dictates frequent administration to maintain therapeutic drug levels, low potential for metabolic activation and/or high susceptibility to catabolism, and the rapid development of resistance by HIV-1. …
In Vitro Anti-Hepatitis B Virus Activities Of 5’-O-Myristoyl Analogue Derivatives Of 3’-Fluoro-2’,3’-Dideoxythymidine (Flt) And 3’-Azido-2’,3’- Dideoxythymidine (Azt), Keykavous Parang, Leonard I. Wiebe, Edward E. Knaus, Jyy-Shiang Huang, David L. Tyrrell
In Vitro Anti-Hepatitis B Virus Activities Of 5’-O-Myristoyl Analogue Derivatives Of 3’-Fluoro-2’,3’-Dideoxythymidine (Flt) And 3’-Azido-2’,3’- Dideoxythymidine (Azt), Keykavous Parang, Leonard I. Wiebe, Edward E. Knaus, Jyy-Shiang Huang, David L. Tyrrell
Pharmacy Faculty Articles and Research
The objective of this study was to evaluate a dual action prodrug concept wherein an unnatural myristic acid analogue is coupled via an ester moiety to the 5’-position of FLT or AZT. Subsequent intracellular cleavage of the prodrug ester would simultaneously release FLT or AZT that could inhibit reverse transcriptase (RT), and the myristic acid analogue that could inhibit myristoyl- CoA:protein N-myristoyltransferase (NMT). Methods: Cytotoxicity (2.2.15 cell culture), and antihepatitis B activity of 5’-O-myristoyl analogue prodrug derivatives of FLT and AZT (2-8) were evaluated in vitro using human liver hepatitis B virus (HBV) producing 2.2.15 cell lines. Results: The 5’- …